Medical Product Regulatory Affairs
Pharmaceuticals, Diagnostics, Medical Devices
(Sprache: Englisch)
Viel Information zum attraktiven Preis: In diesem übersichtlich strukturierten, prägnant formulierten Buch finden Sie alle wichtigen gesetzlichen Vorschriften für den internationalen Pharma- und Medizingerätemarkt. Nach einer kurzen...
Leider schon ausverkauft
versandkostenfrei
Buch (Gebunden)
Fr. 146.90
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Medical Product Regulatory Affairs “
Viel Information zum attraktiven Preis: In diesem übersichtlich strukturierten, prägnant formulierten Buch finden Sie alle wichtigen gesetzlichen Vorschriften für den internationalen Pharma- und Medizingerätemarkt. Nach einer kurzen Einführung in den Prozess der Wirkstoffentwicklung und -zulassung werden nationale Bestimmungen, EU-Recht, USA-Recht, die Vergabe von Herstell- und Vermarktungslizenzen, CDER-/CBER-Richtlinien sowie relevante Teile von GLP, GCP und GMP behandelt.
Klappentext zu „Medical Product Regulatory Affairs “
Written in a clear and concise style by an experienced author, this attractively-priced book covers regulatory affairs in all major global markets for pharmaceuticals and medical devices, making it the most comprehensive in its field.Following a look at drug development, complete sections are devoted to national and EU regulatory issues, manufacturing license application and retention, and regulation in the USA. Other topics dealt with include CDER, CBER and marketing and manufacturing licenses, the ICH process and Good Laboratory/Clinical/Manufacturing Practices.Everything pharmacologists, bioengineers, pharma engineers, students in pharmacy and those working in the pharmaceutical industry need to know about medical regulatory affairs.
Inhaltsverzeichnis zu „Medical Product Regulatory Affairs “
- What is a drug, and what is a device? Basic principles and definitions of healthcare products- The regulatory framework: FDA, EMEA, other regulatory authorities
- The drug development process: pre-clinical and clinical studies
- Medical devices: design control, validation, risk management
- Regulatory submissions: forms and requirements
- Quality systems: GMP, ISO norms, software validation
- Post-marketing issues: surveillance, corrective and preventive actions
- World harmonization of regulatory requirements
Autoren-Porträt von John J. Tobin, Gary Walsh
J.J. Tobin worked for many years and in various capacities within Olympus diagnostica GmbH, a company employing several 100 people who develop and manufacture in vitro diagnostic reagents. Dr. Tobin therefore has extensive experience of working within an FDA and European medical device regulatory framework.Gary Walsh is a senior lecturer in industrial biochemistry at the University of Limerick, Ireland. He has direct industrial experience within the pharmaceutical industry, as well as extensive teaching and non-laboratory based research interests in the pharmaceutical biotechnology arena. He has published a number of books, book chapters and journal articles relevant to this publication. He also teaches elements of pharmaceutical science and regulatory affairs on an annual course provided by the University of Limerick to an international medical device company with a manufactoring facility based in the region.
Bibliographische Angaben
- Autoren: John J. Tobin , Gary Walsh
- 2008, XIV, 283 Seiten, 1 farbige Abbildungen, 113 Schwarz-Weiss-Abbildungen, 80 Abbildungen, Masse: 17,6 x 24,9 cm, Gebunden, Englisch
- Verlag: Wiley-VCH
- ISBN-10: 3527318771
- ISBN-13: 9783527318773
- Erscheinungsdatum: 15.07.2008
Sprache:
Englisch
Rezension zu „Medical Product Regulatory Affairs “
"This book is an excellent reference for people starting out in regulatory affairs, as well as those working within the area whose product portfolio is adapting and changing." ( Microbiology Today , May 2009)
Pressezitat
"This book is an excellent reference for people starting out in regulatory affairs, as well as those working within the area whose product portfolio is adapting and changing." ( Microbiology Today , May 2009)
Kommentar zu "Medical Product Regulatory Affairs"
0 Gebrauchte Artikel zu „Medical Product Regulatory Affairs“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Medical Product Regulatory Affairs".
Kommentar verfassen